SEC Form 4 · accession 0001144204-15-072636
Edesa Biotech, Inc. · EDSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Catherine Brisson
Officer — Chief Operating Officer
Period of report
Dec 22, 2015
Accepted (ET)
Dec 23, 2015 · 5:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001540159
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F1 | $7.24 | Dec 22, 2015 | A | 10,000 | A | — | Dec 18, 2022 | Common Shares | 10,000 | 10,000 | D |
Explanation of responses
- F1Option grant under the 2013 Fixed Share Option Plan (the "Plan"), which shall vest as to one-third immediately, as to one-third on December 22, 2016 and as to the remaining one-third on June 22, 2017.